Search Results 81-90 of 259 for ✉sbc가입코드 【위너보증.com / 가입코드 9122】 대출갤러리 ✉

  1. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...

  2. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage ...

  3. Phase 2a Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of VTX2735 in participants with symptomatic recurrent pericarditis. Participation ...

  4. Losartan for Outpatients on COVID-19 - Clinical Trials

    About this study. This is a multicenter randomized controlled trial comparing losartan vs placebo for outpatients with COVID. Every patient that is tested ...

  5. Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency - Mayo Clinic

    About this study. The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose ...

  6. Temsirolimus and Bevacizumab in Treating Patients with Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer - Mayo Clinic

    This phase II trial studies how well temsirolimus and bevacizumab work in treating patients with advanced endometrial, ovarian, liver, carcinoid, or islet cell ...

  7. Study of Hemodynamic-GUIDEd Management of Heart Failure - Mayo Clinic

    About this study. The purpose of this GUIDE-HF IDE clinical trial is to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient ...

  8. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in ...

  9. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

    About this study. Pazopanib is FDA approved as a second line and beyond treatment for metastatic soft tissue sarcoma. There is a population of elderly and ...